Peter Anthony Campochiaro
Professor
Ophthalmology
Johns Hopkins University
United States of America
Biography
Dr. Campochiaro was trained at the University of Notre Dame, Johns Hopkins School of Medicine, the University of Virginia, and Wilmer, joining the Wilmer Faculty in 1991. He is currently the George S. and Dolores Dor Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Institute. His major research interests are in gaining a greater understanding of the roles of peptide growth and trophic factors in the retina and retinal pigmented-epithelium with an ultimate goal of developing new treatments for proliferative retinopathies, choroidal neovascularization and retinal degenerations.
Research Interest
Mechanisms involved in ocular neovascularization; Development of new treatments for ocular neovascularization; Mechanisms involved in retinal degenerations; Development of new treatments for retinal degenerations; Ocular Gene Therapy; Clinical trials of ocular neovascularization and macular edema
Publications
-
e Silva, Raquel Lima, et al. "Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage." Science translational medicine 9.373 (2017): eaai8030.
-
Campochiaro, Peter A., et al. "Increased Frequency of Topical Steroids Provides Benefit in Patients With Recalcitrant Postsurgical Macular Edema." American Journal of Ophthalmology 178 (2017): 163-175.
-
Heier, Jeffrey S., et al. "Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial." The Lancet (2017).
